Systems Approaches to Cancer Biology Meeting
癌症生物学会议的系统方法
基本信息
- 批准号:10467608
- 负责人:
- 金额:$ 2.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAddressAreaBiological ProcessCOVID-19 pandemicCancer BiologyCollaborationsCommunitiesComplexComputer ModelsData ScienceData SetDevelopmentDisciplineDiseaseEngineeringEnvironmentEquilibriumEventFamilyFosteringFundingFutureGender IdentityGene ProteinsGenomicsGeographyGoalsGrowthHeterogeneityHybridsIndividualIndustryInternationalLeadMalignant NeoplasmsMarketingMathematicsMeasurementMentorshipMethodsMindModelingMolecularMolecular BiologyNational Cancer InstituteOccupationsOralOutcomePatientsPersonsPhysicsPlant RootsPrizeRecording of previous eventsResearchResearch PersonnelRunningScienceScientific Advances and AccomplishmentsScientistSystemSystems BiologyTechnologyTimeWorkanticancer researchcareercomputer sciencedesigndynamic systemepigenomicsethnic identityfallsgenome-widegraduate studentinterestmathematical modelmeetingsnovelnovel strategiespeerpostersprofessorprogramsracial identityrecruitsymposiumtranslational oncologyvirtual
项目摘要
SUMMARY
The Systems Approaches to Cancer Biology (SACB) meeting aims to bring together scientific leaders and
early-stage investigators in Cancer Systems Biology to build and foster a thriving and collaborative field by
sharing scientific advances. Started as a grassroots effort from early-stage Cancer Systems Biology
investigators, the first SACB meeting was held in 2016 and is held every other year. SACB has been
sponsored by the National Cancer Institute and continues to be sponsored by the Association for Cancer
Systems Biologists (ACSB). The meeting is solely focused on research topics that address cancer as
inherently complex, with spatial, temporal, and interpatient heterogeneity, and with multifactorial causes and
consequences that cannot be understood without integrating diverse approaches from a combination of
traditional scientific disciplines. The SACB meeting consists of six plenary sessions, as well as poster
sessions, special topic sessions, and many opportunities for early-stage investigators to network and gain
mentorship from more senior investigators. SACB plenary sessions focus on many aspects of cancer biology
and cover a diversity of computational/mathematical modeling approaches. This problem-domain-focused (as
opposed to methods-focused) programming is particularly conducive to the synthesis of new ideas and
collaborations among attendees. Given the history of this meeting, there is a strong emphasis on the
development and fostering of early-stage investigators, which includes at least half of the oral presentations
being given by trainees and addressing topics of interest to early-stage investigators through special topic
sessions. Another focus of the meeting is to grow the Cancer Systems Biology community, which we will
accomplish by targeting underserved research communities and reaching out to researchers in complementary
topic areas, such as computer science or engineering. We will also provide funding support for early-stage
investigators to attend the meeting, as well as funding support for investigators with additional family needs.
SACB has successfully helped to advance the careers of many early-stage investigators and brings together
like-minded scientists to share research findings. Moving forward, and building on a very successful virtual
meeting in 2020, SACB will become a hybrid meeting, with both in-person and virtual meeting options. This will
provide a venue for SACB to reach colleagues across the world and still be able to provide the intimate
environment needed to foster Cancer Systems Biology research into the future.
概括
这些系统的癌症生物学方法(SACB)旨在将科学领导者和
癌症系统生物学的早期研究人员,建立和培养一个蓬勃发展和协作的领域
分享科学进步。最初是从早期癌症系统生物学的基层工作
调查人员是第一次SACB会议于2016年举行,每隔一年举行一次。 SACB一直在
由国家癌症研究所赞助,并继续由癌症协会赞助
系统生物学家(ACSB)。该会议仅专注于研究癌症的研究主题
固有的复杂,具有空间,时间和室内异质性,以及多因素原因和
如果不整合各种方法的结合,就无法理解的后果
传统科学学科。 SACB会议由六次全体会议和海报组成
会议,特殊主题会议以及早期调查人员进行网络和获得的许多机会
来自更多高级调查员的指导。 SACB全体会议的重点是癌症生物学的许多方面
并涵盖各种计算/数学建模方法。这个问题域的重点(如
反对以方法为重点的)编程特别有利于综合新思想和
与会者之间的合作。鉴于这次会议的历史,很强调
早期研究人员的开发和培养,其中至少包括一半的口头演示
由学员提供,并通过特殊主题向早期调查人员讲述感兴趣的主题
会议。会议的另一个重点是发展癌症系统生物学社区,我们将
通过针对服务不足的研究社区并与互补的研究人员接触来完成
主题领域,例如计算机科学或工程。我们还将为早期提供资金支持
调查人员参加会议,并为有更多家庭需求的调查人员提供资金支持。
SACB成功地帮助推进了许多早期调查人员的职业,并汇集了
志趣相投的科学家分享研究结果。前进,并建立非常成功的虚拟
SACB在2020年的会议上将成为一场混合会议,并提供面对面和虚拟会议选项。这会
为SACB提供了一个到达世界各地同事的场所,并且仍然能够提供亲密
促进对未来的生物学研究所需的环境。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James Christopher Costello其他文献
James Christopher Costello的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James Christopher Costello', 18)}}的其他基金
NPEPPS is a novel and druggable determinant of chemotherapy resistance in bladder cancer
NPEPPS 是膀胱癌化疗耐药的新型可药物决定因素
- 批准号:
10527232 - 财政年份:2022
- 资助金额:
$ 2.58万 - 项目类别:
NPEPPS is a novel and druggable determinant of chemotherapy resistance in bladder cancer
NPEPPS 是膀胱癌化疗耐药的新型可药物决定因素
- 批准号:
10662535 - 财政年份:2022
- 资助金额:
$ 2.58万 - 项目类别:
Curated prostate cancer data for novel and reproducible prognostic modeling
精心策划的前列腺癌数据用于新颖且可重复的预后模型
- 批准号:
9979264 - 财政年份:2020
- 资助金额:
$ 2.58万 - 项目类别:
Systems analysis of aggressive prostate cancer pathology
侵袭性前列腺癌病理学的系统分析
- 批准号:
10247753 - 财政年份:2019
- 资助金额:
$ 2.58万 - 项目类别:
Systems analysis of aggressive prostate cancer pathology
侵袭性前列腺癌病理学的系统分析
- 批准号:
10462763 - 财政年份:2019
- 资助金额:
$ 2.58万 - 项目类别:
Systems analysis of aggressive prostate cancer pathology
侵袭性前列腺癌病理学的系统分析
- 批准号:
10681271 - 财政年份:2019
- 资助金额:
$ 2.58万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
University of Louisville Biomedical Integrative Opportunity for Mentored Experience Development -PREP (UL-BIOMED-PREP)
路易斯维尔大学生物医学综合指导经验开发机会 -PREP (UL-BIOMED-PREP)
- 批准号:
10557638 - 财政年份:2023
- 资助金额:
$ 2.58万 - 项目类别:
Addressing Surgical Disparities at the Root; Working to improve diversity in the surgical workforce
从根本上解决手术差异;
- 批准号:
10639471 - 财政年份:2023
- 资助金额:
$ 2.58万 - 项目类别:
Protein Phosphorylation Networks in Health and Disease
健康和疾病中的蛋白质磷酸化网络
- 批准号:
10682983 - 财政年份:2023
- 资助金额:
$ 2.58万 - 项目类别:
Develop an engineered Cas effector for in vivo cell-targeted delivery in the eye to treat autosomal dominant BEST disease
开发工程化 Cas 效应器,用于眼内体内细胞靶向递送,以治疗常染色体显性 BEST 疾病
- 批准号:
10668167 - 财政年份:2023
- 资助金额:
$ 2.58万 - 项目类别: